A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes

Nasser M. Al-Daghri, Mario Clerici, Omar Al-Attas, Diego Forni, Majed S. Alokail, Khalid M. Alkharfy, Shaun Sabico, Abdul Khader Mohammed, Rachele Cagliani, Manuela Sironi

Research output: Contribution to journalArticle

Abstract

The TLR5 gene encodes an innate immunity receptor. Mice lacking Tlr5 (T5KO) develop insulin resistance and increased adiposity. Owing to the segregation of a dominant nonsense polymorphism (R392X, rs5744168), a portion of humans lack TLR5 function. We investigated whether the nonsense polymorphism influences obesity and susceptibility to type 2 diabetes (T2D). R392X was genotyped in two cohorts from Saudi Arabia, a region where obesity and type 2 diabetes (T2D) are highly prevalent. The nonsense allele was found to protect from obesity (p combined = 0.0062; odds ratio, 0.51) and to associate with lower body mass index (BMI) (pcombined = 0.0061); this allele also correlated with a reduced production of proinflammatory cytokines. A significant interaction was noted between rs5744168 and sex in affecting BMI (p interaction = 0.006), and stratification by gender revealed that the association is driven by females (pcombined = 0.0016 and 0.0006 for obesity and BMI, respectively). The nonsense polymorphism also associated with BMI in nonobese women. After correction for BMI, the 392X allele was found to represent a risk factor for T2D with a sex-specific effect (p interaction = 0.023) mediated by females (p = 0.021; odds ratio, 2.60). Fasting plasma glucose levels in nondiabetic individuals were also higher in women carrying the nonsense allele (p = 0.012). Thus, in contrast to T5KO mice, loss of human TLR5 function protects from weight gain, but in analogy to the animal model, the nonsense allele predisposes to T2D. These effects are apparently sex-specific. Data in this study reinforce the hypothesis that metabolic diseases, including T2D, are associated with immune dysregulation.

Original languageEnglish
Pages (from-to)3716-3720
Number of pages5
JournalJournal of Immunology
Volume190
Issue number7
DOIs
Publication statusPublished - Apr 1 2013

Fingerprint

Type 2 Diabetes Mellitus
Body Mass Index
Obesity
Alleles
Odds Ratio
Saudi Arabia
Metabolic Diseases
Adiposity
Innate Immunity
Weight Gain
Insulin Resistance
Fasting
Animal Models
Cytokines
Glucose
Genes

ASJC Scopus subject areas

  • Immunology

Cite this

A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes. / Al-Daghri, Nasser M.; Clerici, Mario; Al-Attas, Omar; Forni, Diego; Alokail, Majed S.; Alkharfy, Khalid M.; Sabico, Shaun; Mohammed, Abdul Khader; Cagliani, Rachele; Sironi, Manuela.

In: Journal of Immunology, Vol. 190, No. 7, 01.04.2013, p. 3716-3720.

Research output: Contribution to journalArticle

Al-Daghri, Nasser M. ; Clerici, Mario ; Al-Attas, Omar ; Forni, Diego ; Alokail, Majed S. ; Alkharfy, Khalid M. ; Sabico, Shaun ; Mohammed, Abdul Khader ; Cagliani, Rachele ; Sironi, Manuela. / A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes. In: Journal of Immunology. 2013 ; Vol. 190, No. 7. pp. 3716-3720.
@article{36282878feb942ea86ad05421a07648b,
title = "A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes",
abstract = "The TLR5 gene encodes an innate immunity receptor. Mice lacking Tlr5 (T5KO) develop insulin resistance and increased adiposity. Owing to the segregation of a dominant nonsense polymorphism (R392X, rs5744168), a portion of humans lack TLR5 function. We investigated whether the nonsense polymorphism influences obesity and susceptibility to type 2 diabetes (T2D). R392X was genotyped in two cohorts from Saudi Arabia, a region where obesity and type 2 diabetes (T2D) are highly prevalent. The nonsense allele was found to protect from obesity (p combined = 0.0062; odds ratio, 0.51) and to associate with lower body mass index (BMI) (pcombined = 0.0061); this allele also correlated with a reduced production of proinflammatory cytokines. A significant interaction was noted between rs5744168 and sex in affecting BMI (p interaction = 0.006), and stratification by gender revealed that the association is driven by females (pcombined = 0.0016 and 0.0006 for obesity and BMI, respectively). The nonsense polymorphism also associated with BMI in nonobese women. After correction for BMI, the 392X allele was found to represent a risk factor for T2D with a sex-specific effect (p interaction = 0.023) mediated by females (p = 0.021; odds ratio, 2.60). Fasting plasma glucose levels in nondiabetic individuals were also higher in women carrying the nonsense allele (p = 0.012). Thus, in contrast to T5KO mice, loss of human TLR5 function protects from weight gain, but in analogy to the animal model, the nonsense allele predisposes to T2D. These effects are apparently sex-specific. Data in this study reinforce the hypothesis that metabolic diseases, including T2D, are associated with immune dysregulation.",
author = "Al-Daghri, {Nasser M.} and Mario Clerici and Omar Al-Attas and Diego Forni and Alokail, {Majed S.} and Alkharfy, {Khalid M.} and Shaun Sabico and Mohammed, {Abdul Khader} and Rachele Cagliani and Manuela Sironi",
year = "2013",
month = "4",
day = "1",
doi = "10.4049/jimmunol.1202936",
language = "English",
volume = "190",
pages = "3716--3720",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "7",

}

TY - JOUR

T1 - A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes

AU - Al-Daghri, Nasser M.

AU - Clerici, Mario

AU - Al-Attas, Omar

AU - Forni, Diego

AU - Alokail, Majed S.

AU - Alkharfy, Khalid M.

AU - Sabico, Shaun

AU - Mohammed, Abdul Khader

AU - Cagliani, Rachele

AU - Sironi, Manuela

PY - 2013/4/1

Y1 - 2013/4/1

N2 - The TLR5 gene encodes an innate immunity receptor. Mice lacking Tlr5 (T5KO) develop insulin resistance and increased adiposity. Owing to the segregation of a dominant nonsense polymorphism (R392X, rs5744168), a portion of humans lack TLR5 function. We investigated whether the nonsense polymorphism influences obesity and susceptibility to type 2 diabetes (T2D). R392X was genotyped in two cohorts from Saudi Arabia, a region where obesity and type 2 diabetes (T2D) are highly prevalent. The nonsense allele was found to protect from obesity (p combined = 0.0062; odds ratio, 0.51) and to associate with lower body mass index (BMI) (pcombined = 0.0061); this allele also correlated with a reduced production of proinflammatory cytokines. A significant interaction was noted between rs5744168 and sex in affecting BMI (p interaction = 0.006), and stratification by gender revealed that the association is driven by females (pcombined = 0.0016 and 0.0006 for obesity and BMI, respectively). The nonsense polymorphism also associated with BMI in nonobese women. After correction for BMI, the 392X allele was found to represent a risk factor for T2D with a sex-specific effect (p interaction = 0.023) mediated by females (p = 0.021; odds ratio, 2.60). Fasting plasma glucose levels in nondiabetic individuals were also higher in women carrying the nonsense allele (p = 0.012). Thus, in contrast to T5KO mice, loss of human TLR5 function protects from weight gain, but in analogy to the animal model, the nonsense allele predisposes to T2D. These effects are apparently sex-specific. Data in this study reinforce the hypothesis that metabolic diseases, including T2D, are associated with immune dysregulation.

AB - The TLR5 gene encodes an innate immunity receptor. Mice lacking Tlr5 (T5KO) develop insulin resistance and increased adiposity. Owing to the segregation of a dominant nonsense polymorphism (R392X, rs5744168), a portion of humans lack TLR5 function. We investigated whether the nonsense polymorphism influences obesity and susceptibility to type 2 diabetes (T2D). R392X was genotyped in two cohorts from Saudi Arabia, a region where obesity and type 2 diabetes (T2D) are highly prevalent. The nonsense allele was found to protect from obesity (p combined = 0.0062; odds ratio, 0.51) and to associate with lower body mass index (BMI) (pcombined = 0.0061); this allele also correlated with a reduced production of proinflammatory cytokines. A significant interaction was noted between rs5744168 and sex in affecting BMI (p interaction = 0.006), and stratification by gender revealed that the association is driven by females (pcombined = 0.0016 and 0.0006 for obesity and BMI, respectively). The nonsense polymorphism also associated with BMI in nonobese women. After correction for BMI, the 392X allele was found to represent a risk factor for T2D with a sex-specific effect (p interaction = 0.023) mediated by females (p = 0.021; odds ratio, 2.60). Fasting plasma glucose levels in nondiabetic individuals were also higher in women carrying the nonsense allele (p = 0.012). Thus, in contrast to T5KO mice, loss of human TLR5 function protects from weight gain, but in analogy to the animal model, the nonsense allele predisposes to T2D. These effects are apparently sex-specific. Data in this study reinforce the hypothesis that metabolic diseases, including T2D, are associated with immune dysregulation.

UR - http://www.scopus.com/inward/record.url?scp=84875461319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875461319&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1202936

DO - 10.4049/jimmunol.1202936

M3 - Article

C2 - 23455496

AN - SCOPUS:84875461319

VL - 190

SP - 3716

EP - 3720

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 7

ER -